NHC

SEC source: 0001437749-25-015814 · rdgdoc.xml · derivative · entry 6

ABERNATHY JAMES PAUL · CIK 0001261687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-05-07

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 8, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-015791 · rdgdoc.xml · derivative · entry 6

HASSAN EMIL E · CIK 0001288063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2030-05-07

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 8, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-015145 · rdgdoc.xml · derivative · entry 6

LAROCHE RICHARD F JR · CIK 0001012859 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2025-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-015145 · rdgdoc.xml · nonDerivative · entry 1

LAROCHE RICHARD F JR · CIK 0001012859 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-014829 · rdgdoc.xml · derivative · entry 4

ADAMS W ANDREW · CIK 0001012853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2025-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-014829 · rdgdoc.xml · nonDerivative · entry 2

ADAMS W ANDREW · CIK 0001012853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,572

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-013348 · rdgdoc.xml · derivative · entry 2

HASSAN EMIL E · CIK 0001288063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,500 shares

Expires 2025-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-013348 · rdgdoc.xml · nonDerivative · entry 1

HASSAN EMIL E · CIK 0001288063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,595

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-006336 · rdgdoc.xml · nonDerivative · entry 1

KIDD BRIAN F · CIK 0001693922 · SVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,681

F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.

SEC source: 0001437749-25-006329 · rdgdoc.xml · nonDerivative · entry 1

Ussery Robert Michael · CIK 0001313364 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,721

F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.

SEC source: 0001437749-25-006508 · rdgdoc.xml · nonDerivative · entry 1

McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,524

F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.

SEC source: 0001437749-25-006506 · rdgdoc.xml · nonDerivative · entry 1

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,579

F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.

SEC source: 0001437749-25-006504 · rdgdoc.xml · nonDerivative · entry 1

FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,171.0547

F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.

SEC source: 0001437749-25-006499 · rdgdoc.xml · nonDerivative · entry 1

Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,546.5455

F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.

SEC source: 0001437749-25-005285 · rdgdoc.xml · derivative · entry 5

FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2030-02-24

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.

SEC source: 0001437749-25-005287 · rdgdoc.xml · derivative · entry 5

Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2030-02-24

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.

SEC source: 0001437749-25-005283 · rdgdoc.xml · derivative · entry 5

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2030-02-28

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.

SEC source: 0001437749-25-005281 · rdgdoc.xml · derivative · entry 5

Ussery Robert Michael · CIK 0001313364 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2030-02-24

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.

SEC source: 0001437749-25-005279 · rdgdoc.xml · derivative · entry 5

McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2030-02-24

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.

SEC source: 0001437749-25-005276 · rdgdoc.xml · derivative · entry 5

KIDD BRIAN F · CIK 0001693922 · SVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,500

Underlying: Common Stock · 13,500 shares

Expires 2030-02-24

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.

SEC source: 0001437749-25-005273 · rdgdoc.xml · derivative · entry 5

Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2030-02-24

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.

SEC source: 0001437749-25-005247 · rdgdoc.xml · derivative · entry 2

Trail Sandra Y. · CIK 0001910870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,886 shares

Expires 2027-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-005247 · rdgdoc.xml · nonDerivative · entry 1

Trail Sandra Y. · CIK 0001910870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-004609 · rdgdoc.xml · derivative · entry 2

ABERNATHY JAMES PAUL · CIK 0001261687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,010

Underlying: Common Stock · 5,755 shares

Expires 2026-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-004609 · rdgdoc.xml · nonDerivative · entry 1

ABERNATHY JAMES PAUL · CIK 0001261687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,023

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-25-000236 · rdgdoc.xml · nonDerivative · entry 1

Ussery Robert Michael · CIK 0001313364 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,038

F1 · shares: On 1/1/2025, 33 1/3 (or 2,799 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 1,194 shares to pay tax obligations.

SEC source: 0001437749-25-000231 · rdgdoc.xml · nonDerivative · entry 1

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,665

F1 · shares: On 1/1/2025, 33 1/3 (or 3,029 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 1,292 shares to pay tax obligations.

SEC source: 0001437749-25-000227 · rdgdoc.xml · nonDerivative · entry 1

McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,139

F1 · shares: On 1/1/2025, 33 1/3 (or 1,338 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 571 shares to pay tax obligations.

SEC source: 0001437749-25-000223 · rdgdoc.xml · nonDerivative · entry 1

KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,235

F1 · shares: On 1/1/2025, 33 1/3 (or 1,359 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 512 shares to pay tax obligations.

SEC source: 0001437749-25-000220 · rdgdoc.xml · nonDerivative · entry 1

FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,580.1586

F1 · shares: On 1/1/2025, 33 1/3 (or 1,352 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 510 shares to pay tax obligations.

SEC source: 0001437749-25-000217 · rdgdoc.xml · nonDerivative · entry 1

Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,600.5455

F1 · shares: On 1/1/2025, 33 1/3 (or 958 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 361 shares to pay tax obligations.

SEC source: 0001437749-26-000353 · rdgdoc.xml · nonDerivative · entry 1

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,147

F1 · shares: On 1/1/2026, 33 1/3 (or 2400 shares) of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 1024 shares to pay tax obligations.

SEC source: 0001437749-25-000275 · rdgdoc.xml · nonDerivative · entry 1

NATIONAL HEALTH CORP · CIK 0000719730 · Affiliate

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,030,887

SEC source: 0001437749-25-000059 · rdgdoc.xml · nonDerivative · entry 3

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,957

F2 · balance_after: Total amount of shares beneficially owned following transactions reported on this form.

SEC source: 0001437749-25-000059 · rdgdoc.xml · nonDerivative · entry 2

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · balance_after: Transaction totaled on the line below for securities of this title.

SEC source: 0001437749-25-000059 · rdgdoc.xml · nonDerivative · entry 1

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · balance_after: Transaction totaled on the line below for securities of this title.

SEC source: 0001437749-24-038396 · rdgdoc.xml · nonDerivative · entry 1

NATIONAL HEALTH CORP · CIK 0000719730 · Affiliate

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,056,616

SEC source: 0001437749-25-000490 · rdgdoc.xml · nonDerivative · entry 1

Shelly Timothy J. · CIK 0002031428 · Sr.VP Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001437749-24-036974 · rdgdoc.xml · nonDerivative · entry 1

Ussery Robert Michael · CIK 0001313364 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,232

SEC source: 0001437749-24-036490 · rdgdoc.xml · derivative · entry 2

Trail Sandra Y. · CIK 0001910870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,886

Underlying: Common Stock · 3,886 shares

Expires 2027-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-24-036490 · rdgdoc.xml · nonDerivative · entry 1

Trail Sandra Y. · CIK 0001910870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-24-031481 · rdgdoc.xml · nonDerivative · entry 4

ADAMS W ANDREW · CIK 0001012853 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Trustee

Disclosed balance after: 0

F1 · shares: Mr. Adams serves as trustee of the Trust of which his children are beneficiaries. On September 27, 2024, Mr. Adams, in his capacity as trustee, caused the trust to distribute 2,307 shares of NHC common stock to the trust's beneficiaries as part of his estate planning. The shares remain subject to a Lock-Up Agreement, which continues to apply to recipients of the stock.

SEC source: 0001437749-24-028566 · rdgdoc.xml · nonDerivative · entry 1

KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,747

SEC source: 0001437749-24-027024 · rdgdoc.xml · nonDerivative · entry 1

ABERNATHY JAMES PAUL · CIK 0001261687 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,278

SEC source: 0001437749-24-027092 · rdgdoc.xml · nonDerivative · entry 1

Flatt Stephen Fowler · CIK 0001330766 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,042

SEC source: 0001437749-24-026868 · rdgdoc.xml · derivative · entry 3

ADAMS ROBERT G · CIK 0001012855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 7,500 shares

Expires 2026-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-24-026868 · rdgdoc.xml · nonDerivative · entry 2

ADAMS ROBERT G · CIK 0001012855 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Trustee

Disclosed balance after: 9,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

SEC source: 0001437749-24-020219 · rdgdoc.xml · derivative · entry 4

McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 12,000 shares

Expires 2028-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-24-020219 · rdgdoc.xml · nonDerivative · entry 2

McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,710

F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations.

F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form.

SEC source: 0001437749-24-020219 · rdgdoc.xml · nonDerivative · entry 1

McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).